The Rise of Patient Support Programs: Opportunities for Pharma
Advanced, well-designed patient support programs (PSP) are central to pharma’s patient centricity agenda and can deliver multiple stakeholder and commercial benefits. But challenges remain. How can you build awareness of your PSP? In what ways is digital technology driving PSP innovation and outcomes? What are the downsides of PSP generated pharmacovigilance data? How can PSPs play into your go-to-market strategy? In this report, experts reveal practical strategies for developing and delivering powerful and productive PSPs.
Roche, GlaxoSmithKline, AstraZeneca, Sanofi, Merck & Co., Bristol Myers Squibb, Daiichi Sankyo, Microsoft, Deloitte, Patchai
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook